A detailed history of Cowen Prime Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 500 shares of ABT stock, worth $57,965. This represents 0.02% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$57,965
Previous $55,000 1.82%
% of portfolio
0.02%
Previous 0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 01, 2022

BUY
$76.57 - $98.0 $38,285 - $49,000
500 New
500 $54,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Cowen Prime Advisors LLC Portfolio

Follow Cowen Prime Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cowen Prime Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cowen Prime Advisors LLC with notifications on news.